Epigenomics: Andrew Lukowiak

The supervisory board of Epigenomics has appointed Andrew Lukowiak as president and CSO, effective Dec. 1. Lukowiak will become a member of Epigenomics' executive board and will oversee research and development, as well as operations. Lukowiak previously served as CEO and board member for Millennium Health, chief operating officer at AltheaDx, and senior research and development executive at GenMark Diagnostics and Hologic.